review article | Q7318358 |
scholarly article | Q13442814 |
P2093 | author name string | Hackstein H | |
Thomson AW | |||
Morelli AE | |||
P2860 | cites work | Effects of liver-derived dendritic cell progenitors on Th1- and Th2-like cytokine responses in vitro and in vivo | Q73368144 |
Serrate1-induced notch signalling regulates the decision between immunity and tolerance made by peripheral CD4(+) T cells | Q73399528 | ||
CD8alpha(+) (lymphoid-related) and CD8alpha(-) (myeloid) dendritic cells differentially regulate vascularized organ allograft survival | Q73667312 | ||
Microchimerism, donor dendritic cells, and alloimmune reactivity in recipients of Flt3 ligand-mobilized hemopoietic cells: modulation by tacrolimus | Q73910746 | ||
Blockade of the CD40-CD40 ligand pathway potentiates the capacity of donor-derived dendritic cell progenitors to induce long-term cardiac allograft survival | Q74015557 | ||
The effect of calcineurin inhibitors and corticosteroids on the differentiation of human dendritic cells | Q74164913 | ||
Mycophenolate mofetil impairs the maturation and function of murine dendritic cells | Q74183071 | ||
Prolonged skin allograft survival in mice treated with Flt3-ligand-induced dendritic cells and anti-CD154 monoclonal antibody | Q74616832 | ||
The NF-kappa B and I kappa B proteins: new discoveries and insights | Q24313579 | ||
Class I-restricted cross-presentation of exogenous self-antigens leads to deletion of autoreactive CD8(+) T cells | Q24653129 | ||
Dendritic cells use macropinocytosis and the mannose receptor to concentrate macromolecules in the major histocompatibility complex class II compartment: downregulation by cytokines and bacterial products | Q24678867 | ||
Notch signaling: cell fate control and signal integration in development | Q27861061 | ||
Aspirin inhibits in vitro maturation and in vivo immunostimulatory function of murine myeloid dendritic cells | Q28184794 | ||
1 Alpha,25-dihydroxyvitamin D3 inhibits differentiation, maturation, activation, and survival of dendritic cells leading to impaired alloreactive T cell activation | Q28370605 | ||
Immunobiology of dendritic cells | Q29547465 | ||
Direct and indirect recognition: the role of MHC antigens in graft rejection | Q33546858 | ||
Recombinant adenovirus induces maturation of dendritic cells via an NF-kappaB-dependent pathway | Q33811694 | ||
Natural adjuvants: endogenous activators of dendritic cells | Q33878894 | ||
Costimulatory molecule-deficient dendritic cell progenitors (MHC class II+, CD80dim, CD86-) prolong cardiac allograft survival in nonimmunosuppressed recipients | Q35160185 | ||
Antigen-specific inhibition of effector T cell function in humans after injection of immature dendritic cells | Q36369028 | ||
Freshly isolated Peyer's patch, but not spleen, dendritic cells produce interleukin 10 and induce the differentiation of T helper type 2 cells | Q36375116 | ||
Recombinant galectin-1 and its genetic delivery suppress collagen-induced arthritis via T cell apoptosis | Q36375186 | ||
Consequences of cell death: exposure to necrotic tumor cells, but not primary tissue cells or apoptotic cells, induces the maturation of immunostimulatory dendritic cells | Q36375909 | ||
CD4+ T cell tolerance to parenchymal self-antigens requires presentation by bone marrow-derived antigen-presenting cells | Q36400881 | ||
Resting respiratory tract dendritic cells preferentially stimulate T helper cell type 2 (Th2) responses and require obligatory cytokine signals for induction of Th1 immunity | Q36401161 | ||
Prolongation of cardiac allograft survival using dendritic cells treated with NF-kB decoy oligodeoxyribonucleotides | Q38309722 | ||
Immature dendritic cells generated with low doses of GM-CSF in the absence of IL-4 are maturation resistant and prolong allograft survival in vivo | Q40752701 | ||
Directed differentiation of dendritic cells from mouse embryonic stem cells. | Q40837850 | ||
A dendritic cell line genetically modified to express CTLA4-IG as a means to prolong islet allograft survival | Q40882028 | ||
Blockade of T cell activation using a surface-linked single-chain antibody to CTLA-4 (CD152). | Q40884227 | ||
Induction of antigen-specific immunosuppression by CD95L cDNA-transfected 'killer' dendritic cells | Q40938855 | ||
Retroviral delivery of viral interleukin-10 into myeloid dendritic cells markedly inhibits their allostimulatory activity and promotes the induction of T-cell hyporesponsiveness | Q40981826 | ||
A discrete subpopulation of dendritic cells transports apoptotic intestinal epithelial cells to T cell areas of mesenteric lymph nodes | Q42039464 | ||
Targeted expression of major histocompatibility complex (MHC) class II molecules demonstrates that dendritic cells can induce negative but not positive selection of thymocytes in vivo | Q42113339 | ||
Induction of interleukin 10-producing, nonproliferating CD4(+) T cells with regulatory properties by repetitive stimulation with allogeneic immature human dendritic cells | Q42944333 | ||
Dendritic cell survival and maturation are regulated by different signaling pathways. | Q42971737 | ||
Feasibility of CTLA4Ig gene delivery and expression in vivo using retrovirally transduced myeloid dendritic cells that induce alloantigen-specific T cell anergy in vitro | Q44321933 | ||
Autoantigen-pulsed dendritic cells induce tolerance to experimental allergic encephalomyelitis (EAE) in Lewis rats | Q44577649 | ||
Transfer of dendritic cells (DC) ex vivo stimulated with interferon-gamma (IFN-gamma) down-modulates autoimmune diabetes in non-obese diabetic (NOD) mice. | Q53928842 | ||
IL-10 prevents the differentiation of monocytes to dendritic cells but promotes their maturation to macrophages | Q56943349 | ||
Effective treatment of established murine collagen-induced arthritis by systemic administration of dendritic cells genetically modified to express IL-4 | Q64380123 | ||
Synergy in induction of increased renal allograft survival after portal vein infusion of dendritic cells transduced to express TGFbeta and IL-10, along with administration of CHO cells expressing the regulatory molecule OX-2 | Q64380678 | ||
Contrasting effects of TGF-beta 1 and TNF-alpha on the development of dendritic cells from progenitors in mouse bone marrow | Q73197413 | ||
Immunotherapy of NOD mice with bone marrow-derived dendritic cells | Q73224770 | ||
Dendritic cells genetically engineered to express Fas ligand induce donor-specific hyporesponsiveness and prolong allograft survival | Q73289641 | ||
CD40 ligation ablates the tolerogenic potential of lymphoid dendritic cells | Q73311850 | ||
P433 | issue | 8 | |
P921 | main subject | dendritic cell | Q506253 |
P304 | page(s) | 437-442 | |
P577 | publication date | 2001-08-01 | |
P1433 | published in | Trends in Immunology | Q15265730 |
P1476 | title | Designer dendritic cells for tolerance induction: guided not misguided missiles | |
P478 | volume | 22 |
Q53311604 | Additive effects of rapamycin and aspirin on dendritic cell allostimulatory capacity. |
Q36966459 | Adoptive Transfer of Dendritic Cells Expressing Fas Ligand Modulates Intestinal Inflammation in a Model of Inflammatory Bowel Disease |
Q44589808 | Alloantigen presentation by ethylcarbodiimide-treated dendritic cells induces T cell hyporesponsiveness, and prolongs organ graft survival |
Q42739489 | Antigen-based immune therapeutics for type 1 diabetes: magic bullets or ordinary blanks? |
Q37742101 | Approaches for immunological tolerance induction to stem cell-derived cell replacement therapies |
Q34430856 | Atopic disorders: a vaccine around the corner? |
Q33203876 | Biodegradable nanoparticle mediated antigen delivery to human cord blood derived dendritic cells for induction of primary T cell responses |
Q35733829 | Biology of T lymphocytes |
Q38113268 | CD40-activated B cells as antigen-presenting cells: the final sprint toward clinical application |
Q44170968 | CTLA-4-Ig regulates tryptophan catabolism in vivo. |
Q34119204 | Chemokines in cancer |
Q35116303 | Current state of type 1 diabetes immunotherapy: incremental advances, huge leaps, or more of the same? |
Q37754644 | Dendritic cell-based therapy in Type 1 diabetes mellitus |
Q35756961 | Dendritic cells and autoimmunity |
Q45858420 | Dendritic cells genetically engineered to express IL-4 exhibit enhanced IL-12p70 production in response to CD40 ligation and accelerate organ allograft rejection |
Q47794906 | Dendritic cells, engineered to secrete a T-cell receptor mimic peptide, induce antigen-specific immunosuppression in vivo |
Q34740521 | Dendritic cells, tolerance induction and transplant outcome |
Q35620073 | Dendritic cells: emerging pharmacological targets of immunosuppressive drugs |
Q78514187 | Designer dendritic cells for transplant tolerance |
Q48433083 | Elevated bioactivity of the tolerogenic cytokines, interleukin-10 and transforming growth factor-beta, in the blood of acutely malnourished weanling mice |
Q64377947 | Fas-ligand-expressing adenovirus-transfected dendritic cells decrease allergen-specific T cells and airway inflammation in a murine model of asthma |
Q62748555 | How do dendritic cells prevent autoimmunity? |
Q50630386 | Human Chorionic Villous Mesenchymal Stem Cells Modify the Functions of Human Dendritic Cells, and Induce an Anti-Inflammatory Phenotype in CD1+ Dendritic Cells. |
Q35681340 | Immune system paralysis by anthrax lethal toxin: the roles of innate and adaptive immunity |
Q36897372 | Immunoregulatory dendritic cells to prevent and reverse new-onset Type 1 diabetes mellitus |
Q81292276 | Induction of peripheral tolerance by local delivery of dendritic cell progenitors to cardiac allografts in a murine heterotopic heart transplantation model |
Q36359678 | Intravenous immunoglobulin and dendritic cells. |
Q34139182 | Killer artificial antigen-presenting cells: the synthetic embodiment of a 'guided missile'. |
Q46422409 | Limitations of CD95 ligand-transduced killer dendritic cells to prevent graft rejections |
Q36602259 | Liposomal vaccines--targeting the delivery of antigen |
Q34154950 | Macrophages and the immune responsiveness of the testis |
Q40588550 | Monitoring immune responses in cancer patients receiving tumor vaccines |
Q44460738 | Neuroblastoma cells inhibit the immunostimulatory function of dendritic cells. |
Q74681820 | Normal donor bone marrow is superior to Flt3 ligand-mobilized bone marrow in prolonging heart allograft survival when combined with anti-CD40L (CD154) |
Q40272991 | Phenotypic analysis of IL-10-treated, monocyte-derived dendritic cells in patients with systemic lupus erythematosus |
Q40688948 | Polybrene and interleukin-4: two opposing factors for retroviral transduction of bone-marrow-derived dendritic cells. |
Q44606335 | Prevention of CD40-triggered dendritic cell maturation and induction of T-cell hyporeactivity by targeting of Janus kinase 3. |
Q35216477 | Prevention of allograft rejection by in vitro generated tolerogenic dendritic cells |
Q42439416 | Regulatory cytokine production stimulated by DNA vaccination against an altered form of glutamic acid decarboxylase 65 in nonobese diabetic mice |
Q35784552 | Role of infiltrated leucocytes in tumour growth and spread |
Q35855829 | Role of surfactant protein A in the innate host defense and autoimmunity |
Q34778048 | T-cell tolerance in allergic response. |
Q34423175 | TGF-beta1 treated murine dendritic cells are maturation resistant and down-regulate Toll-like receptor 4 expression |
Q35549421 | Targeting dendritic cells for priming cellular immune responses |
Q36405777 | The PD-1-PD-L pathway in immunological tolerance |
Q34609715 | The biogenesis and functions of exosomes |
Q37234298 | Thymus-homing peripheral dendritic cells constitute two of the three major subsets of dendritic cells in the steady-state thymus |
Q45884347 | Transforming growth factor beta1-modified donor cell transfusion induced allo-heart tolerance |
Q81352287 | Unexpected effects of viral interleukin-10-secreting dendritic cells in vivo: preferential inhibition of TH2 responses |
Q79820412 | [The role of dendritic cells in immunity. Potential clinical use] |